Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

PLD is an effective and safer alternative for treating breast cancer.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Eating the right nutrients can improve hair health, but taking extra supplements usually doesn't help unless you have a deficiency.

Finasteride improves hair loss in women with hyperandrogenism.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Minoxidil effectively treats female pattern hair loss.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.